BioConvergence LLC, a life sciences contract service provider, makes a big change to respond to client needs.
BLOOMINGTON, INDIANA (PRWEB) JUNE 09, 2016 – BioConvergence LLC announces a major initiative that includes a transition to a new name and an expansion of its services consistent with the company’s strategic plan and vision of CEO Alisa Wright.
“We continually seek new ways to improve patients’ lives by helping our clients accelerate their product development process. This has been our mission from the start of the company ten years ago. This project, like our past expansions, fills a critical need expressed by our clients,” Wright said.
The service expansion will require construction of clean rooms and installation of equipment necessary to fill injectable drug products into vials, syringes, and cartridges for clients in the pharmaceutical industry. This added capability complements the company’s existing services that span from formulation development to finished product for use in clinical trials.
Senior Director of Operations Brent Lieffers said, “This expansion not only brings innovative technology to our clients, but also creates new employment opportunities in our community.”
Concurrent with the expansion, the company name will transition to Singota™ Solutions. This reflects the company’s continued growth as a Contract Development and Manufacturing Organization (CDMO) and its commitment to accelerating the drug development process through innovative solutions.
Lynn Coyne, president of the Bloomington Economic Development Corporation, commented, “This major expansion of an already successful life science company signals a very bright future for BioConvergence. BioConvergence’s creativity and innovation make it a market leader and we are grateful that BioConvergence has chosen to stay and grow in Monroe County.”
Wright added, “On behalf of everyone at the company, we are excited about the future, and we deeply appreciate the support from the local community.” The company will make further announcements as to its progress over the coming months.
BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, labeling and kitting, and supply chain services. Headquartered in Bloomington, Indiana, BioConvergence has over 50 employees with many years of valuable experience in the pharmaceutical and biotechnology industries. The unique E-Transparency® System provides transparency and flexibility to clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.